News Center

COVID-19 Updates for Providers

Harvard Pilgrim committed to supporting our members and providers during this global pandemic. We’re adapting our policies and business operations as needed to ensure that members can quickly and easily access the care they need and to support providers with the challenges posed by this crisis. Please refer to our COVID-19 resources for more information.

Network Matters

July 2021

Read full issue

Highlights

Updates Regarding Oncology Drugs

Cosela, Margenza, and Trodelvy will now require prior authorization through Oncology Analytics when used for oncology purposes for members of Harvard Pilgrim’s commercial and StrideSM (HMO) Medicare Advantage plans.

Check Out Our Latest Provider Training Video

The short training videos on our Provider Training and Events page offer step-by-step guidance around common transactions to make doing business with us easier than ever, and we’ve recently added a new video.

Gynecology Payment Policy Updates

Harvard Pilgrim is making updates concerning cervical or vaginal screening and HPV testing to our commercial Gynecology Payment Policy, effective for dates of service beginning Sept. 1, 2021.